* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
208	AKT2	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	0.680824180352639	BEFREE;CTD_human;HPO;MGD;UNIPROT
208	AKT2	C3278384	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY	0.4	ORPHANET;UNIPROT
208	AKT2	C0032460	Polycystic Ovary Syndrome	0.282956482091714	BEFREE;GAD;HPO;MGD
208	AKT2	C1458155	Mammary Neoplasms	0.205465824929628	CTD_human;LHGDN
208	AKT2	C0023787	Lipodystrophy	0.200824180352639	BEFREE;HPO
208	AKT2	C2711227	Steatohepatitis	0.200549453568426	BEFREE;HPO
208	AKT2	C0005586	Bipolar Disorder	0.200274726784213	BEFREE;PSYGENET
208	AKT2	C0854110	Insulin resistant diabetes	0.200274726784213	BEFREE;HPO
208	AKT2	C0000889	Acanthosis Nigricans	0.2	HPO
208	AKT2	C0014544	Epilepsy	0.2	HPO
208	AKT2	C0018418	Gynecomastia	0.2	HPO
208	AKT2	C0019209	Hepatomegaly	0.2	HPO
208	AKT2	C0021655	Insulin Resistance	0.2	HPO
208	AKT2	C0028949	Oligomenorrhea	0.2	HPO
208	AKT2	C0036572	Seizures	0.2	HPO
208	AKT2	C0158986	Neonatal hypoglycemia	0.2	HPO
208	AKT2	C0271694	Familial partial lipodystrophy	0.2	CTD_human
208	AKT2	C0311277	Obesity, Abdominal	0.2	HPO
208	AKT2	C0332890	Congenital hemihypertrophy	0.2	HPO
208	AKT2	C1136382	Sclerocystic Ovaries	0.2	HPO
208	AKT2	C1522137	Hypertriglyceridemia result	0.2	HPO
208	AKT2	C1835390	Increased intraabdominal fat	0.2	HPO
208	AKT2	C1837802	Decreased serum leptin	0.2	HPO
208	AKT2	C1848395	Large for gestational age	0.2	HPO
208	AKT2	C2712907	combined hyperlipidemia	0.2	HPO
208	AKT2	C2931822	Nasopharyngeal carcinoma	0.2	CTD_human
208	AKT2	C4020899	Autosomal recessive predisposition	0.2	HPO
208	AKT2	C4073127	Decreased adiponectin level	0.2	HPO
208	AKT2	C2239176	Liver carcinoma	0.0841065463858792	BEFREE;LHGDN;RGD
208	AKT2	C0022116	Ischemia	0.08	RGD
208	AKT2	C0027055	Myocardial Reperfusion Injury	0.08	RGD
208	AKT2	C0017638	Glioma	0.0071141856349061	BEFREE;LHGDN
208	AKT2	C0919267	ovarian neoplasm	0.0060152784980537	BEFREE;LHGDN
208	AKT2	C0242379	Malignant neoplasm of lung	0.0059129641834284	BEFREE;GAD
208	AKT2	C0007137	Squamous cell carcinoma	0.00355709281745305	BEFREE;LHGDN
208	AKT2	C0677886	Epithelial ovarian cancer	0.0035059356601404	BEFREE;GAD
208	AKT2	C0029925	Ovarian Carcinoma	0.0030219946263441	BEFREE
208	AKT2	C0001418	Adenocarcinoma	0.00300763924902685	BEFREE;LHGDN
208	AKT2	C0011849	Diabetes Mellitus	0.00300763924902685	BEFREE;LHGDN
208	AKT2	C0025517	Metabolic Diseases	0.00300763924902685	BEFREE;LHGDN
208	AKT2	C0030297	Pancreatic Neoplasm	0.00300763924902685	BEFREE;LHGDN
208	AKT2	C0033578	Prostatic Neoplasms	0.00300763924902685	BEFREE;LHGDN
208	AKT2	C0006142	Malignant neoplasm of breast	0.002747267842131	BEFREE
208	AKT2	C0596263	Carcinogenesis	0.002747267842131	BEFREE
208	AKT2	C0020456	Hyperglycemia	0.00273291246481375	LHGDN
208	AKT2	C0036341	Schizophrenia	0.0026817553075011	BEFREE;GAD
208	AKT2	C0027627	Neoplasm Metastasis	0.0024725410579179	BEFREE
208	AKT2	C0678222	Breast Carcinoma	0.0024725410579179	BEFREE
208	AKT2	C0001420	Papillary adenocarcinoma	0.002407028523288	GAD
208	AKT2	C0019693	HIV Infections	0.002407028523288	GAD
208	AKT2	C0040136	Thyroid Neoplasm	0.002407028523288	GAD
208	AKT2	C0546837	Malignant neoplasm of esophagus	0.002407028523288	GAD
208	AKT2	C0346647	Malignant neoplasm of pancreas	0.0021978142737048	BEFREE
208	AKT2	C1140680	Malignant neoplasm of ovary	0.0019230874894917	BEFREE
208	AKT2	C0235974	Pancreatic carcinoma	0.0016483607052786	BEFREE
208	AKT2	C0017636	Glioblastoma	0.0013736339210655	BEFREE
208	AKT2	C0376358	Malignant neoplasm of prostate	0.0013736339210655	BEFREE
208	AKT2	C0600139	Prostate carcinoma	0.0013736339210655	BEFREE
208	AKT2	C0007131	Non-Small Cell Lung Carcinoma	0.0010989071368524	BEFREE
208	AKT2	C0020615	Hypoglycemia	0.0010989071368524	BEFREE
208	AKT2	C0024623	Malignant neoplasm of stomach	0.0010989071368524	BEFREE
208	AKT2	C0476089	Endometrial Carcinoma	0.0010989071368524	BEFREE
208	AKT2	C0684249	Carcinoma of lung	0.0010989071368524	BEFREE
208	AKT2	C0699791	Stomach Carcinoma	0.0010989071368524	BEFREE
208	AKT2	C1306460	Primary malignant neoplasm of lung	0.0010989071368524	BEFREE
208	AKT2	C0007103	Malignant neoplasm of endometrium	0.0008241803526393	BEFREE
208	AKT2	C0025202	melanoma	0.0008241803526393	BEFREE
208	AKT2	C0027819	Neuroblastoma	0.0008241803526393	BEFREE
208	AKT2	C0524620	Metabolic Syndrome X	0.0008241803526393	BEFREE
208	AKT2	C0555198	Malignant Glioma	0.0008241803526393	BEFREE
208	AKT2	C0700095	Central neuroblastoma	0.0008241803526393	BEFREE
208	AKT2	C1883486	Uterine Corpus Cancer	0.0008241803526393	BEFREE
208	AKT2	C0024299	Lymphoma	0.0005494535684262	BEFREE
208	AKT2	C0079731	B-Cell Lymphomas	0.0005494535684262	BEFREE
208	AKT2	C0079772	T-Cell Lymphoma	0.0005494535684262	BEFREE
208	AKT2	C0152013	Adenocarcinoma of lung (disorder)	0.0005494535684262	BEFREE
208	AKT2	C0686619	Secondary malignant neoplasm of lymph node	0.0005494535684262	BEFREE
208	AKT2	C1335302	Pancreatic Ductal Adenocarcinoma	0.0005494535684262	BEFREE
208	AKT2	C1621958	Glioblastoma Multiforme	0.0005494535684262	BEFREE
208	AKT2	C0002895	Anemia, Sickle Cell	0.0002747267842131	BEFREE
208	AKT2	C0003486	Aortic Aneurysm	0.0002747267842131	BEFREE
208	AKT2	C0003850	Arteriosclerosis	0.0002747267842131	BEFREE
208	AKT2	C0004135	Ataxia Telangiectasia	0.0002747267842131	BEFREE
208	AKT2	C0004153	Atherosclerosis	0.0002747267842131	BEFREE
208	AKT2	C0005684	Malignant neoplasm of urinary bladder	0.0002747267842131	BEFREE
208	AKT2	C0005695	Bladder Neoplasm	0.0002747267842131	BEFREE
208	AKT2	C0007102	Malignant tumor of colon	0.0002747267842131	BEFREE
208	AKT2	C0009402	Colorectal Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0011847	Diabetes	0.0002747267842131	BEFREE
208	AKT2	C0020459	Hyperinsulinism	0.0002747267842131	BEFREE
208	AKT2	C0020538	Hypertensive disease	0.0002747267842131	BEFREE
208	AKT2	C0024121	Lung Neoplasms	0.0002747267842131	BEFREE
208	AKT2	C0026470	Monoclonal Gammopathy of Undetermined Significance	0.0002747267842131	BEFREE
208	AKT2	C0026764	Multiple Myeloma	0.0002747267842131	BEFREE
208	AKT2	C0027809	Neurilemmoma	0.0002747267842131	BEFREE
208	AKT2	C0028754	Obesity	0.0002747267842131	BEFREE
208	AKT2	C0029463	Osteosarcoma	0.0002747267842131	BEFREE
208	AKT2	C0029927	Ovarian Cysts	0.0002747267842131	BEFREE
208	AKT2	C0030193	Pain	0.0002747267842131	BEFREE
208	AKT2	C0032002	Pituitary Diseases	0.0002747267842131	BEFREE
208	AKT2	C0032927	Precancerous Conditions	0.0002747267842131	BEFREE
208	AKT2	C0037579	Soft Tissue Neoplasms	0.0002747267842131	BEFREE
208	AKT2	C0041956	Ureteral obstruction	0.0002747267842131	BEFREE
208	AKT2	C0043037	Common wart	0.0002747267842131	BEFREE
208	AKT2	C0149925	Small cell carcinoma of lung	0.0002747267842131	BEFREE
208	AKT2	C0151650	Renal fibrosis	0.0002747267842131	BEFREE
208	AKT2	C0153381	Malignant neoplasm of mouth	0.0002747267842131	BEFREE
208	AKT2	C0153405	Malignant neoplasm of pharynx	0.0002747267842131	BEFREE
208	AKT2	C0153452	Malignant neoplasm of gallbladder	0.0002747267842131	BEFREE
208	AKT2	C0153567	Uterine Cancer	0.0002747267842131	BEFREE
208	AKT2	C0178874	Tumor Progression	0.0002747267842131	BEFREE
208	AKT2	C0220641	Lip and Oral Cavity Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0220989	Acquired partial lipodystrophy	0.0002747267842131	BEFREE
208	AKT2	C0235782	Gallbladder Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0238198	Gastrointestinal Stromal Tumors	0.0002747267842131	BEFREE
208	AKT2	C0262584	Carcinoma, Small Cell	0.0002747267842131	BEFREE
208	AKT2	C0271650	Impaired glucose tolerance	0.0002747267842131	BEFREE
208	AKT2	C0278688	Stage IV Ovarian Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0278701	Gastric Adenocarcinoma	0.0002747267842131	BEFREE
208	AKT2	C0279626	Squamous cell carcinoma of esophagus	0.0002747267842131	BEFREE
208	AKT2	C0279671	Cervical Squamous Cell Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0280100	solid tumor	0.0002747267842131	BEFREE
208	AKT2	C0424295	Hyperactive behavior	0.0002747267842131	BEFREE
208	AKT2	C0494165	Secondary malignant neoplasm of liver	0.0002747267842131	BEFREE
208	AKT2	C0585442	Osteosarcoma of bone	0.0002747267842131	BEFREE
208	AKT2	C0598766	Leukemogenesis	0.0002747267842131	BEFREE
208	AKT2	C0699790	Colon Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C0699885	Carcinoma of bladder	0.0002747267842131	BEFREE
208	AKT2	C0729233	Dissecting aneurysm of the thoracic aorta	0.0002747267842131	BEFREE
208	AKT2	C0853879	Invasive carcinoma of breast	0.0002747267842131	BEFREE
208	AKT2	C0947751	Vascular inflammations	0.0002747267842131	BEFREE
208	AKT2	C1266129	Atypical Lipoma	0.0002747267842131	BEFREE
208	AKT2	C1302401	Adenoma of large intestine	0.0002747267842131	BEFREE
208	AKT2	C1370889	Liposarcoma, well differentiated	0.0002747267842131	BEFREE
208	AKT2	C1561643	Chronic Kidney Diseases	0.0002747267842131	BEFREE
208	AKT2	C1654637	androgen independent prostate cancer	0.0002747267842131	BEFREE
208	AKT2	C3811653	Experimental Organism Basal Cell Carcinoma	0.0002747267842131	BEFREE
208	AKT2	C3887486	Interstitial lung fibrosis	0.0002747267842131	BEFREE
208	AKT2	C4049711	Lepidic Predominant Adenocarcinoma	0.0002747267842131	BEFREE